BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 19287496)

  • 1. FOXM1 upregulation is an early event in human squamous cell carcinoma and it is enhanced by nicotine during malignant transformation.
    Gemenetzidis E; Bose A; Riaz AM; Chaplin T; Young BD; Ali M; Sugden D; Thurlow JK; Cheong SC; Teo SH; Wan H; Waseem A; Parkinson EK; Fortune F; Teh MT
    PLoS One; 2009; 4(3):e4849. PubMed ID: 19287496
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FOXM1 allows human keratinocytes to bypass the oncogene-induced differentiation checkpoint in response to gain of MYC or loss of p53.
    Molinuevo R; Freije A; de Pedro I; Stoll SW; Elder JT; Gandarillas A
    Oncogene; 2017 Feb; 36(7):956-965. PubMed ID: 27452522
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppression of FOXM1 Transcriptional Activities via a Single-Stranded DNA Aptamer Generated by SELEX.
    Xiang Q; Tan G; Jiang X; Wu K; Tan W; Tan Y
    Sci Rep; 2017 Mar; 7():45377. PubMed ID: 28358012
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tobacco carcinogen metabolites and DNA adducts as biomarkers in head and neck cancer: potential screening tools and prognostic indicators.
    Khariwala SS; Hatsukami D; Hecht SS
    Head Neck; 2012 Mar; 34(3):441-7. PubMed ID: 21618325
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Splicing Factor DDX23, Transcriptionally Activated by E2F1, Promotes Ovarian Cancer Progression by Regulating FOXM1.
    Zhao C; Li Y; Qiu C; Chen J; Wu H; Wang Q; Ma X; Song K; Kong B
    Front Oncol; 2021; 11():749144. PubMed ID: 34966670
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HELLS regulates transcription in T-cell lymphomas by reducing unscheduled R-loops and by facilitating RNAPII progression.
    Tameni A; Mallia S; Manicardi V; Donati B; Torricelli F; Vitale E; Salviato E; Gambarelli G; Muccioli S; Zanelli M; Ascani S; Martino G; Sanguedolce F; Sauta E; Tamagnini I; Puccio N; Neri A; Ciarrocchi A; Fragliasso V
    Nucleic Acids Res; 2024 Apr; ():. PubMed ID: 38597676
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [WITHDRAWN] Novel FOXM1 inhibitor STL001 sensitizes human cancers to a broad-spectrum of cancer therapies.
    Res Sq; 2024 Jan; ():. PubMed ID: 38234752
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FOXM1 induces a global methylation signature that mimics the cancer epigenome in head and neck squamous cell carcinoma.
    Teh MT; Gemenetzidis E; Patel D; Tariq R; Nadir A; Bahta AW; Waseem A; Hutchison IL
    PLoS One; 2012; 7(3):e34329. PubMed ID: 22461910
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of human epithelial stem/progenitor expansion by FOXM1.
    Gemenetzidis E; Elena-Costea D; Parkinson EK; Waseem A; Wan H; Teh MT
    Cancer Res; 2010 Nov; 70(22):9515-26. PubMed ID: 21062979
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FoxM1 promotes β-catenin nuclear localization and controls Wnt target-gene expression and glioma tumorigenesis.
    Zhang N; Wei P; Gong A; Chiu WT; Lee HT; Colman H; Huang H; Xue J; Liu M; Wang Y; Sawaya R; Xie K; Yung WK; Medema RH; He X; Huang S
    Cancer Cell; 2011 Oct; 20(4):427-42. PubMed ID: 22014570
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Upregulation of FOXM1 induces genomic instability in human epidermal keratinocytes.
    Teh MT; Gemenetzidis E; Chaplin T; Young BD; Philpott MP
    Mol Cancer; 2010 Feb; 9():45. PubMed ID: 20187950
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of FOXM1-induced epigenetic markers for head and neck squamous cell carcinomas.
    Hwang S; Mahadevan S; Qadir F; Hutchison IL; Costea DE; Neppelberg E; Liavaag PG; Waseem A; Teh MT
    Cancer; 2013 Dec; 119(24):4249-58. PubMed ID: 24114764
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Downstream targets of FOXM1: CEP55 and HELLS are cancer progression markers of head and neck squamous cell carcinoma.
    Waseem A; Ali M; Odell EW; Fortune F; Teh MT
    Oral Oncol; 2010 Jul; 46(7):536-42. PubMed ID: 20400365
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integrating bioinformatics and experimental models to investigate the mechanism of the chelidonine-induced mitotic catastrophe via the AKT/FOXO3/FOXM1 axis in breast cancer cells.
    Li H; Tang X; Sun Z; Qu Z; Zou X
    Biomol Biomed; 2024 May; 24(3):560-574. PubMed ID: 37976368
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HPV Infection is Associated with FoxM1 Overexpression in Dysplastic Changes of Sinonasal Inverted Papilloma.
    Rachmadi L; Billianti Susanto YD; Sitinjak D; Manatar AF; Saraswati M; Adham M
    Asian Pac J Cancer Prev; 2022 Dec; 23(12):4293-4298. PubMed ID: 36580012
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcriptome Analysis Reveals Vimentin-Induced Disruption of Cell-Cell Associations Augments Breast Cancer Cell Migration.
    Usman S; Jamal A; Bushaala A; Waseem NH; Al-Dehlawi H; Yeudall WA; Teh MT; Tummala H; Waseem A
    Cells; 2022 Dec; 11(24):. PubMed ID: 36552797
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Schwann Cells Induce Phenotypic Changes in Oral Cancer Cells.
    Santi MD; Zhang M; Salvo E; Asam K; Viet CT; Xie T; Amit M; Aouizerat B; Ye Y
    Adv Biol (Weinh); 2022 Sep; 6(9):e2200187. PubMed ID: 35925609
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of N-Terminal Tags on De Novo Vimentin Intermediate Filament Assembly.
    Usman S; Aldehlawi H; Nguyen TKN; Teh MT; Waseem A
    Int J Mol Sci; 2022 Jun; 23(11):. PubMed ID: 35683030
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The potential role of nicotine in breast cancer initiation, development, angiogenesis, invasion, metastasis, and resistance to therapy.
    Khodabandeh Z; Valilo M; Velaei K; Pirpour Tazehkand A
    Breast Cancer; 2022 Sep; 29(5):778-789. PubMed ID: 35583594
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.